Source-grounded facts extracted from AdaptHealth Corp.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
AdaptHealth Corp. shareholders approved A non-binding advisory vote to approve the compensation paid to the Company's named executive officers at the 2026-06-18 meeting.
“3. Non-binding advisory vote to approve the compensation paid to the Company’s named executive officers. For Against Abstain Broker Non-Vote 107,129,368 965,272 682,032 11,875,821 Based on the votes set forth above, the stockholders approved this proposal on an advisory basis.”
AdaptHealth Corp. shareholders approved To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.
“2. Ratification of Appointment of Independent Registered Public Accounting Firm. For Against Abstain 119,090,024 1,092,126 470,343 Based on the votes set forth above, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
AdaptHealth Corp. shareholders approved To elect nine directors for a one-year term at the 2026-06-18 meeting.
“1. Election of Directors. Name For Withheld Broker Non-Vote Gregory Belinfanti 106,611,172 2,165,500 11,875,821 Terence Connors 106,470,008 2,306,664 11,875,821 Brad Coppens 107,111,674 1,664,998 11,875,821 Suzanne Foster 105,992,570 2,784,102 11,875,821 Ted Lundberg 102,690,918 6,085,754 11,875,821 Kenneth A. Samet 108,390,299 386,373 11,875,821 Dr. Susan Weaver 106,714,121 2,062,551 11,875,821 David Williams III 106,543,756 2,232,916 11,875,821 Dale Wolf 105,844,287 2,932,385 11,875,821 Based on the votes set forth above, each director nominee was duly elected”
Daniel McFadden was appointed as Chief Operating Officer at AdaptHealth Corp..
“the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026”
AdaptHealth Corp. reported first quarter ended March 31, 2026 results: revenue $819.8 million, net income $16.0 million. Guidance raised.
“the Company's portfolio around its core Sleep and Respiratory Health businesses. First Quarter Results All comparisons are to the quarter ended March 31, 2025. • Net revenue was $819.8 million compared to $777.9 million, an increase of 5.4%. • Organic revenue growth of 9.1%, with growth across each of the Company’s reportable segments. • Net loss attributable to”
Daniel McFadden was appointed as Chief Operating Officer at AdaptHealth Corp..
“Also on May 4, 2026, the Company appointed Daniel McFadden, the Company’s current Chief Business Systems Officer, as the Company’s Chief Operating Officer.”
Toby Scott Barnhart was terminated as Chief Operating Officer at AdaptHealth Corp..
“On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company’s Chief Operating Officer.”
AdaptHealth Corp. incurred credit facility of $450.0 million in revolving loan commitments, with a $75.0 million letter of credit sublimit, $325.0 million in initial with Bank of America, N.A., as administrative agent at SOFR loans ranges from 1.125% to 2.000% per annum maturing the earlier to occur of April 13, 2031 and a springing maturity date that is ninety-one (91) days prior to the stated maturity date of the 2028 Senior Notes.
“The Credit Agreement provides for $450.0 million in revolving loan commitments, with a $75.0 million letter of credit sublimit, $325.0 million in initial term loans, and, for a period of up to two years following the closing of the Credit Agreement, $325.0 million in delayed draw term loan commitments.”
AdaptHealth Corp. entered into Credit Agreement with Bank of America, N.A., as administrative agent, the lenders and other parties valued at $450.0 million in revolving loan commitments (effective 2026-04-10).
“On April 10, 2026, AdaptHealth LLC (the “Borrower”), a subsidiary of AdaptHealth Corp., a Delaware corporation (the “Company”), entered into a credit agreement (the “Credit Agreement”) among AdaptHealth Intermediate Holdco LLC, a Delaware limited liability company and Borrower’s direct parent (“Intermediate Holdings”), the Borrower, certain wholly-owned subsidiaries of the Borrower, Bank of America, N.A., as administrative agent, the lenders and other parties party thereto.”
Diana L. Nole was appointed as Director at AdaptHealth Corp..
“On October 16, 2024, following the recommendation of the nominating and governance committee of AdaptHealth Corp. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Diana L. Nole, age 59, to the Board, effective October 16, 2024.”
Toby Scott Barnhart was appointed as Chief Operating Officer at AdaptHealth Corp..
“Toby Scott Barnhart, age 56, has been appointed to serve as the Chief Operating Officer of the Company, effective as of September 23, 2024”
Shaw Rietkerk changed role as Chief Business Officer at AdaptHealth Corp..
“On August 13, 2024, AdaptHealth Corp. (the “Company”) informed Shaw Rietkerk of its intention to transition him to a new position as the Company’s Chief Business Officer, by the end of September, 2024, following which Mr. Rietkerk will no longer serve as the Company’s Chief Operating Officer.”
Joshua Parnes resigned as President at AdaptHealth Corp..
“the Company and Joshua Parnes, the Company’s President, mutually agreed that Mr. Parnes will resign from all positions that he holds with the Company and its affiliates, effective as of 11:59 p.m. E.D.T. on August 31, 2024”
AdaptHealth Corp. reported first quarter ended March 31, 2024 results: revenue $792.5 million, net income $2.1 million. Guidance reaffirmed.
“Net revenue was $792.5 million compared to $744.6 million, an increase of 6.4%. • Net loss attributable to AdaptHealth Corp. was $2.1 million compared to net income of $15.7 million.”
Suzanne Foster was appointed as Director at AdaptHealth Corp..
“Upon starting as Chief Executive Officer, Ms. Foster will also be appointed to serve as a member of the Company’s board of directors”
Suzanne Foster was appointed as Chief Executive Officer at AdaptHealth Corp..
“Suzanne Foster, age 54, has been appointed to serve as the Chief Executive Officer of the Company, effective May 20, 2024.”
AdaptHealth Corp. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue Net revenue was $3,200.2 million, net income Net loss attributable to AdaptHealth Corp. was $678.9 million. Guidance initiated.
“announced today financial results for the fourth quarter and fiscal year ended December 31, 2023. Full Year 2023 Results and Highlights All comparisons are to the year ended December 31, 2022 unless otherwise stated. • Net revenue was $3,200.2 million compared to $2,970.6 million, an increase of 7.7% driven by non-acquired growth of 7.3%. • Net loss attributable to AdaptHealth Corp. was $678.9 million compared to net income of $69.3 million”
AdaptHealth Corp. reported third quarter ended September 30, 2023 results: revenue $804.0 million, net income Net loss attributable to AdaptHealth Corp. was $454.1 million. Guidance lowered.
“quarter ended September 30, 2023. Third Quarter Results and Highlights All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. • Net revenue was $804.0 million compared to $756.5 million, an increase of 6.3%. • Net loss attributable to AdaptHealth Corp. was $454.1 million compared to net income of $16.1 million, largely resulting from a”
Richard Barasch changed role as Interim Chief Executive Officer at AdaptHealth Corp..
“Mr. Barasch has agreed to continue to serve as the Interim Chief Executive Officer of the Company until October 31, 2023 or such earlier date as determined by the Board of Directors of the Company (the “Transition Date”).”
AdaptHealth Corp. reported the second quarter ended June 30, 2023 results: revenue $793.3 million, net income $14.0 million. Guidance lowered.
“AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Net revenue was $793.3 million compared to $727.6 million, an increase of 9.0% . ◦ Non-acquired net revenue growth was 8.7%. • Net income attributable to AdaptHealth Corp. was $14.0 million, compared to $14.0 million.”
Crispin Teufel was appointed as Chief Executive Officer at AdaptHealth Corp..
“Crispin Teufel, age 47, has been appointed to serve as the Chief Executive Officer of the Company, effective September 1, 2023.”
AdaptHealth Corp. shareholders approved Non-binding advisory vote to approve the compensation paid to the Company's named executive officers at the 2023-06-21 meeting.
“3. Non-binding advisory vote to approve the compensation paid to the Company's named executive officers. For Against Abstain Broker Non-Vote 82,245,888 989,731 17,221 14,598,068”
AdaptHealth Corp. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-21 meeting.
“2. Ratification of Appointment of Independent Registered Public Accounting Firm. For Against Abstain 97,283,371 553,816 13,721”
AdaptHealth Corp. shareholders approved Election of Class I Directors at the 2023-06-21 meeting.
“1. Election of Class I Directors. Name For Withheld Broker Non-Vote Richard Barasch 49,170,889 34,081,951 14,598,068 Gregory Belinfanti 75,439,182 7,813,658 14,598,068”
AdaptHealth Corp. reported first quarter ended March 31, 2023 results: revenue Net revenue was $744.6 million, net income Net income attributable to AdaptHealth Corp. was $15.7 million.
“medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2023. First Quarter Results and Highlights • Net revenue was $744.6 million compared to $706.2 million in the first quarter of 2022, an increase of 5.4%, including 17.6% growth in our Sleep categories. • Non-acquired growth was 4.7%. • Net income”
Stephen P. Griggs departed as Director at AdaptHealth Corp..
“It is further agreed that Mr. Griggs will not stand for reelection as a member of the Company’s Board of Directors (the “Board”) at the Company’s annual meeting currently scheduled for June 21, 2023.”
Stephen P. Griggs departed as Chief Executive Officer at AdaptHealth Corp..
“On May 8 , 2023, AdaptHealth Corp. (the “Company”) and Stephen P. Griggs, Chief Executive Officer of the Company, mutually agreed that Mr. Griggs will resign as Chief Executive Officer of the Company, effective as of 11:59 p.m. E.D.T. on June 30, 2023”
Jason Clemens changed role as Principal Accounting Officer at AdaptHealth Corp..
“In connection with Ms. Archbold’s promotion, Mr. Clemens will no longer serve as principal accounting officer of the Company effective March 10, 2023.”
Shaw Rietkerk changed role as Chief Operating Officer at AdaptHealth Corp..
“On March 13, 2023, the Company promoted Shaw Rietkerk to Chief Operating Officer of the Company.”
Christine Archbold changed role as Chief Accounting Officer at AdaptHealth Corp..
“On March 10, 2023, AdaptHealth Corp. (the “Company”) promoted Christine Archbold to Chief Accounting Officer and principal accounting officer of the Company.”
AdaptHealth Corp. reported fiscal year 2023 results: revenue Net revenue of $3.160 billion to $3.240 billion. Guidance lowered.
“The Company is updating its initial financial guidance for fiscal year 2023, as follows: • Net revenue of $3.160 billion to $3.240 billion (previously $3.210 billion to $3.290 billion); • Adjusted EBITDA of $650 million to $710 million (previously $690 million to $750 million); • Total capital expenditures representing 10-12% of net revenue (previously 9-11% of net revenue).”
AdaptHealth Corp. reported the fiscal year ended December 31, 2022 results: net income Net income attributable to AdaptHealth Corp. was $69.3 million, or $0.33 per diluted share, EPS $0.33 per diluted share.
“Net income attributable to AdaptHealth Corp. was $69.3 million, or $0.33 per diluted share, compared to $156.2 million, or $0.67 per diluted share, in 2021.”
AdaptHealth Corp. reported the fourth quarter of 2022 results: revenue $780.3 million, net income Net loss attributable to AdaptHealth Corp. was $2.6 million, or $(0.02) per diluted share, EPS $(0.02) per diluted share.
“AdaptHealth reported Net revenue of $780.3 million for the fourth quarter of 2022 compared to $702.1 million in the fourth quarter of 2021, an increase of 11.1% including non-acquired growth of 5.3%.”
AdaptHealth Corp. reported full year 2022 results: revenue net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion.
“the Company anticipates net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion”
AdaptHealth Corp. reported fiscal year 2023 results: revenue $3.210 billion to $3.290 billion. Guidance initiated.
“Based on current business, market trends, and acquisitions completed to date, the Company is establishing initial guidance for fiscal year 2023 as follows: · Net revenue of $3.210 billion to $3.290 billion; · Adjusted EBITDA of $690 million to $750 million; and · Total capital expenditures are expected to be 9-11% of net revenue. Guidance for fiscal year 2023”
AdaptHealth Corp. reported preliminary financial results for fourth quarter 2022.
“ADAPTHEALTH PROVIDES Full-year 2023 Guidance AND Preliminary Commentary on Fourth Quarter 2022 REsults”
AdaptHealth Corp. reported financial results for three and nine months ended September 30, 2022.
“On November 8, 2022, AdaptHealth Corp. (the “Company”) issued a press release (the “Press Release”) announcing financial results for the three and nine months ended September 30, 2022.”
Jason Clemens was appointed as principal accounting officer at AdaptHealth Corp..
“Jason Clemens, the Company’s Chief Financial Officer and principal financial officer, will serve as principal accounting officer until a permanent replacement for Mr. Mullen is appointed.”
Frank Mullen resigned as Chief Accounting Officer at AdaptHealth Corp..
“On November 19, 2021, Frank Mullen, the Chief Accounting Officer of AdaptHealth Corp., a Delaware corporation (the “Company”), notified the Company that he will be leaving the Company effective May 16, 2022.”
Greg Belinfanti was appointed as Director at AdaptHealth Corp..
“On September 30, 2021, following the recommendation of the nominating and governance committee of AdaptHealth Corp. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Greg Belinfanti to the Board.”
Alan Quasha resigned as Director at AdaptHealth Corp..
“On August 24, 2021, Alan Quasha submitted a notice of resignation, effective as of September 1, 2021, as a member of the Board of Directors of AdaptHealth Corp.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.